Store My Library
About Contact
Research Behind Her Guide โ€” midlifebridge
midlifebridge ยท Her Guide

The Research Behind
Everything We Teach

Every claim in Her Guide is grounded in peer-reviewed research, clinical guidelines, and evidence from tens of thousands of women. This page is where we show our work.

"You deserve to know where this information comes from. Not because it makes it more trustworthy โ€” but because it was always yours to have."

Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Full Reference List
Week 1

Your Body Didn't Break. The Rules Changed.

Week 1 covers estrogen, progesterone, cortisol, and sleep โ€” the foundation of everything that follows. Here is the research behind what Kaia describes.

Estrogen as a regulatory system
Estrogen does more than regulate reproduction โ€” it touches mood, memory, sleep, metabolism, bone, cardiovascular function, and inflammatory response.
  • Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509โ€“522.
  • Shanmugan S, Epperson CN. Estrogen and the prefrontal cortex: towards a new understanding of estrogen's effects on executive functions in the menopause transition. Human Brain Mapping. 2014;35(2):847โ€“865.
  • NIH Office of Research on Women's Health. Menopause and the brain. Available at: orwh.od.nih.gov.
Progesterone and sleep architecture
Progesterone activates GABA pathways โ€” the same system targeted by prescription sleep medications. As it declines, access to deep sleep stages becomes unreliable, producing the 3AM wake-up window.
  • Steiner M et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. Journal of Women's Health. 2006.
  • Freeman EW et al. Sleep disturbance and hormone levels in midlife. Sleep Medicine Reviews. 2007.
  • Polo-Kantola P et al. The effect of short-term estrogen replacement therapy on cognition. Obstetrics & Gynecology. 1998.
The cortisol-insulin loop
As estrogen declines, its buffering effect on the cortisol stress response weakens โ€” leading to visceral fat storage, disrupted sleep, and increased metabolic resistance.
  • Epel ES et al. Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosomatic Medicine. 2000;62(5):623โ€“632.
  • Lovejoy JC et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. International Journal of Obesity. 2008;32(6):949โ€“958.
Sleep disruption in perimenopause
Sleep problems affect the majority of women going through the menopausal transition โ€” and are directly linked to hormonal change, not simply aging or stress.
  • Kravitz HM, Joffe H. Sleep during the perimenopause: a SWAN story. Obstetrics and Gynecology Clinics of North America. 2011;38(3):567โ€“586.
  • Ohayon MM. Severe hot flashes are associated with chronic insomnia. Archives of Internal Medicine. 2006;166(12):1262โ€“1268.
  • Magnesium and sleep: Abbasi B et al. The effect of magnesium supplementation on primary insomnia in elderly. Journal of Research in Medical Sciences. 2012;17(12):1161โ€“1169.
Week 2

It's Not You. It's Your Brain Chemistry.

Week 2 covers the neurotransmitter connection to estrogen โ€” including why mood, focus, and memory change during this transition, and the ADHD unmasking reality.

Estrogen and neurotransmitters
Estrogen supports serotonin, dopamine, and acetylcholine โ€” the chemicals behind mood, motivation, and memory. When estrogen fluctuates, all three are affected simultaneously.
  • Deecher D, Andree TH. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology. 2010;35(9):1282โ€“1312.
  • McEwen BS. Estrogen actions throughout the brain. Recent Progress in Hormone Research. 2002;57:357โ€“384.
  • Sherwin BB. Estrogen and cognitive functioning in women: lessons we have learned. Behavioural Neuroscience. 2012;126(1):123โ€“127.
ADHD unmasking in perimenopause
Many women receive their first ADHD diagnosis in their 40s and 50s โ€” not because they developed a new condition, but because estrogen had been compensating for underlying attention vulnerabilities throughout their adult lives.
  • Epperson CN et al. Menopause effects on verbal memory: findings from a longitudinal community cohort. Journal of Clinical Endocrinology & Metabolism. 2013;98(9):3829โ€“3838.
  • Quinn PO, Madhoo M. A review of attention-deficit/hyperactivity disorder in women and girls: uncovering this hidden diagnosis. The Primary Care Companion for CNS Disorders. 2014.
  • Staller J, Faraone SV. Attention-deficit hyperactivity disorder in girls. Expert Review of Neurotherapeutics. 2006;6(4):565โ€“572.
Rage, anxiety, and hormonal mood changes
Irritability, anxiety, and emotional volatility in perimenopause are neurochemical โ€” linked to estrogen's role in serotonin and GABA regulation, not personality or circumstance.
  • Bromberger JT, Kravitz HM. Mood and menopause: findings from the Study of Women's Health Across the Nation (SWAN). Obstetrics and Gynecology Clinics of North America. 2011;38(3):609โ€“625.
  • Freeman EW et al. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry. 2006;63(4):375โ€“382.
Week 3

Strong Is the New Strategy.

Week 3 covers metabolism, muscle, and the supplement evidence โ€” including why the same food and exercise habits stop producing the same results.

Estrogen and insulin sensitivity
Estrogen plays an active role in insulin sensitivity and glucose regulation. As it declines, the body's ability to process carbohydrates changes โ€” not because of what you eat, but because the hormonal environment that managed it has shifted.
  • Mauvais-Jarvis F et al. Menopause, estrogens, and glucose homeostasis in women. Journal of Diabetes Investigation. 2013;4(3):274โ€“279.
  • Godsland IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein concentrations: analysis of studies published from 1974 to 2000. Fertility and Sterility. 2001.
Muscle as a longevity organ
Muscle mass is one of the most powerful modifiable predictors of long-term functional health and independence. Resistance training is the highest-return metabolic intervention for midlife women.
  • Studenski SA et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50โ€“58.
  • Cruz-Jentoft AJ et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019;48(1):16โ€“31.
  • Bea JW et al. Resistance training predicts 6-year body composition change in postmenopausal women. Obesity. 2010.
The Mediterranean diet and cardiovascular protection
The Mediterranean diet pattern is one of the most evidence-backed nutritional frameworks for midlife women โ€” specifically for cardiovascular protection, inflammation reduction, and insulin sensitivity.
  • Estruch R et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine. 2018;378(25).
  • Sofi F et al. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. American Journal of Clinical Nutrition. 2010;92(5):1189โ€“1196.
Creatine for women in midlife
Creatine monohydrate is one of the most evidence-backed supplements for muscle strength, cognitive function, and bone support in older women โ€” and one of the most underused.
  • Smith-Ryan AE et al. Creatine supplementation in women's health: a lifespan perspective. Nutrients. 2021;13(3):877.
  • Candow DG et al. Efficacy of creatine supplementation on aging muscle and bone. Journal of Clinical Medicine. 2019;8(11):1876.
  • Avgerinos KI et al. Effects of creatine on cognitive function: a systematic review. Experimental Gerontology. 2018;108:166โ€“173.
Week 4

The Doctor Talk. HRT Decoded. The Conversation Nobody Is Having.

Week 4 covers HRT, the WHI study, GSM, testosterone, and how to advocate for yourself in medical appointments.

The WHI study โ€” what it said and what it didn't
The 2002 Women's Health Initiative study used oral conjugated equine estrogen in women averaging age 63. The fear it created was based on a misreading of data that did not apply to women in early perimenopause starting hormone therapy at the right time.
  • Rossouw JE et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women (WHI). JAMA. 2002;288(3):321โ€“333.
  • Manson JE et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the WHI. JAMA. 2013;310(13):1353โ€“1368.
  • The Menopause Society (NAMS). 2022 Hormone Therapy Position Statement. Available at: menopause.org.
  • International Menopause Society; British Menopause Society. Joint consensus statement on menopausal hormone therapy. 2022.
GSM โ€” Genitourinary Syndrome of Menopause
GSM is a documented, named, treatable condition affecting an estimated 50โ€“80% of postmenopausal women. Only about half ever discuss it with a clinician.
  • AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. 2025. Available at: auanet.org.
  • Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The Menopause Society. Menopause. 2014;21(10):1063โ€“1068.
  • Rahn DD et al. Vaginal estrogen for genitourinary syndrome of menopause. Obstetrics & Gynecology. 2014;124(6):1147โ€“1156.
Testosterone for women
Testosterone therapy in women, when appropriately prescribed and monitored, is supported by evidence in carefully selected women for improvements in libido, arousal, energy, and motivation.
  • International Society for the Study of Women's Sexual Health (ISSWSH). Position statement on testosterone therapy for women. Journal of Sexual Medicine. 2019;16(2):296โ€“309.
  • Davis SR et al. Global consensus position statement on the use of testosterone therapy for women. Journal of Clinical Endocrinology & Metabolism. 2019;104(10):4660โ€“4666.
Week 5

The Quiet Systems. Pelvic. Thyroid. Alcohol. Emerging Tools.

Week 5 covers the symptoms that rarely make it into mainstream conversations โ€” and the research that confirms they are real, hormonal, and treatable.

Pelvic floor and bladder in midlife
Estrogen receptors are dense throughout the bladder, urethra, vaginal tissue, and pelvic floor. When estrogen declines, the entire genitourinary system loses structural support โ€” causing urgency, leaking, and recurrent infections that are hormonal, not anatomical failures.
  • Nappi RE et al. Female sexual dysfunction: prevalence and impact on quality of life. Maturitas. 2016;94:87โ€“91.
  • The Menopause Society (NAMS). Genitourinary Syndrome of Menopause Position Statement. 2023. Available at: menopause.org.
  • APTA Academy of Pelvic Health. Clinical Practice Guidelines on Pelvic Floor Disorders. 2023. Available at: pelvicrehab.com.
Thyroid and perimenopause overlap
Thyroid dysfunction and perimenopause produce overlapping symptoms โ€” fatigue, weight gain, brain fog, mood changes โ€” and can occur simultaneously. Thyroid evaluation is a standard part of a thorough midlife assessment.
  • American Thyroid Association. Garber JR et al. Clinical practice guidelines for hypothyroidism in adults. Thyroid. 2012;22(12):1200โ€“1235.
  • NIDDK โ€” National Institute of Diabetes and Digestive and Kidney Diseases. Hypothyroidism. Available at: niddk.nih.gov.
  • FDA Safety Communication. Biotin supplements may interfere with certain lab tests. November 2019. Available at: fda.gov.
Alcohol metabolism changes in midlife
Estrogen plays a regulatory role in how the liver processes alcohol. As it declines, alcohol remains in the system longer, produces stronger effects at lower doses, and disrupts sleep architecture more significantly than it previously did.
  • Baraona E et al. Gender differences in pharmacokinetics of alcohol. Alcoholism: Clinical & Experimental Research. 2001;25(4):502โ€“507.
  • Erol A, Karpyak VM. Sex and gender-related differences in alcohol use and its consequences. Alcohol. 2015;49(4):369โ€“375.
Emerging tools โ€” GLP-1, sauna, NAD+, creatine
Some emerging longevity tools have meaningful evidence โ€” others have promising animal data but limited human trials. midlifebridge applies the same framework to all: mechanism, evidence base, risk profile.
  • GLP-1 medications: Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021;384:989โ€“1002.
  • Sauna โ€” cardiovascular: Laukkanen JA et al. Association between sauna bathing and fatal cardiovascular and all-cause mortality. JAMA Internal Medicine. 2015;175(4):542โ€“548.
  • NAD+ precursors: Yoshino J et al. Nicotinamide mononucleotide, a key NAD+ intermediate. Cell Metabolism. 2018;27(5):1194.
Week 6

The Other Shore. Bone. Heart. Your 30-Year Strategy.

Week 6 covers the longevity picture โ€” cardiovascular risk, bone density, the six longevity pillars, and the MIDUS research on who women become when they cross this bridge with intention.

Heart disease and women
Heart disease is the leading cause of death in women โ€” more than all cancers combined. The menopausal transition is a critical window for cardiovascular risk assessment.
  • American Heart Association. Mosca L et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women โ€” 2011 update. Circulation. 2011;123(11):1243โ€“1262.
  • Centers for Disease Control and Prevention. Heart Disease Facts โ€” Women. 2023. Available at: cdc.gov/heartdisease.
  • Bairey Merz CN et al. Ischemic heart disease and menopause. Journal of the American College of Cardiology. 2017.
Bone density loss at menopause
Bone loss accelerates significantly in the first several years after menopause โ€” often more rapidly than at any other adult life stage. This is preventable with the right interventions started at the right time.
  • International Osteoporosis Foundation. Facts and statistics on osteoporosis and its impact. Available at: iofbonehealth.org.
  • Eastell R et al. Pharmacological management of osteoporosis in postmenopausal women. Journal of Clinical Endocrinology & Metabolism. 2019;104(5):1595โ€“1622.
Purpose, identity, and health outcomes โ€” MIDUS
The Midlife in the United States (MIDUS) longitudinal study โ€” tracking thousands of women across decades โ€” consistently finds that women with a clear sense of purpose and active identity have measurably better health outcomes across virtually every domain.
  • MIDUS โ€” Midlife in the United States Longitudinal Study. University of Wisconsin Institute on Aging. Ongoing since 1994. Available at: midus.wisc.edu.
  • Ryff CD. Psychological well-being revisited: advances in the science and practice of eudaimonia. Psychotherapy and Psychosomatics. 2014;83(1):10โ€“28.
  • Boyle PA et al. Purpose in life is associated with a reduced risk of incident disability among community-dwelling older persons. American Journal of Geriatric Psychiatry. 2010.
Muscle, CoQ10, and statin considerations
Statin medications are among the most commonly prescribed drugs that deplete CoQ10 โ€” a molecule essential for cellular energy and antioxidant function. Women on statins should discuss CoQ10 with their prescribing physician.
  • Littarru GP, Tiano L. Clinical aspects of coenzyme Q10: an update. Nutrition. 2010;26(3):250โ€“254.
  • Studenski SA et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50โ€“58.
Complete Reference Library

Every Source. In One Place.

Alphabetical by category. This is the complete list of clinical guidelines, peer-reviewed research, and government health authority sources that inform Her Guide.

Clinical Guidelines & Position Statements
AUA/SUFU/AUGS. Clinical Guideline on Genitourinary Syndrome of Menopause. 2025.
American Heart Association. Mosca L et al. Effectiveness-based guidelines for prevention of CVD in women. Circulation. 2011;123(11):1243โ€“1262.
American Thyroid Association. Garber JR et al. Clinical practice guidelines for hypothyroidism in adults. Thyroid. 2012;22(12):1200โ€“1235.
APTA Academy of Pelvic Health. Clinical Practice Guidelines on Pelvic Floor Disorders. 2023.
International Menopause Society & British Menopause Society. Joint consensus statement on menopausal hormone therapy. 2022.
International Osteoporosis Foundation. Facts and statistics on osteoporosis and its impact. Available at: iofbonehealth.org.
ISSWSH. Position statement on the use of testosterone therapy for women. Journal of Sexual Medicine. 2019;16(2):296โ€“309.
The Menopause Society (NAMS). 2022 Hormone Therapy Position Statement. Available at: menopause.org.
The Menopause Society (NAMS). Genitourinary Syndrome of Menopause Position Statement. 2023.
Government & Public Health Authorities
CDC. Heart Disease Facts โ€” Women. 2023. Available at: cdc.gov/heartdisease.
FDA. Safety Communication: Biotin supplements may interfere with lab tests. November 2019.
NIDDK โ€” NIH. Hypothyroidism overview. Available at: niddk.nih.gov.
NIH Office of Research on Women's Health. Menopause and the brain. Available at: orwh.od.nih.gov.
Peer-Reviewed Research
Abbasi B et al. The effect of magnesium supplementation on primary insomnia in elderly. Journal of Research in Medical Sciences. 2012;17(12):1161โ€“1169.
Avgerinos KI et al. Effects of creatine on cognitive function: a systematic review. Experimental Gerontology. 2018;108:166โ€“173.
Bairey Merz CN et al. Ischemic heart disease and menopause. Journal of the American College of Cardiology. 2017.
Baraona E et al. Gender differences in pharmacokinetics of alcohol. Alcoholism: Clinical & Experimental Research. 2001;25(4):502โ€“507.
Bea JW et al. Resistance training predicts 6-year body composition change in postmenopausal women. Obesity. 2010.
Boyle PA et al. Purpose in life is associated with a reduced risk of incident disability. American Journal of Geriatric Psychiatry. 2010.
Bromberger JT, Kravitz HM. Mood and menopause: findings from SWAN. Obstetrics and Gynecology Clinics of North America. 2011;38(3):609โ€“625.
Candow DG et al. Efficacy of creatine supplementation on aging muscle and bone. Journal of Clinical Medicine. 2019;8(11):1876.
Cruz-Jentoft AJ et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019;48(1):16โ€“31.
Davis SR et al. Global consensus position statement on testosterone therapy for women. Journal of Clinical Endocrinology & Metabolism. 2019;104(10):4660โ€“4666.
Deecher D, Andree TH. From menarche to menopause: exploring depression in women during hormonal changes. Psychoneuroendocrinology. 2010;35(9):1282โ€“1312.
Eastell R et al. Pharmacological management of osteoporosis in postmenopausal women. Journal of Clinical Endocrinology & Metabolism. 2019;104(5):1595โ€“1622.
Epperson CN et al. Menopause effects on verbal memory: longitudinal community cohort. Journal of Clinical Endocrinology & Metabolism. 2013;98(9):3829โ€“3838.
Epel ES et al. Stress and body shape: cortisol secretion and central fat in women. Psychosomatic Medicine. 2000;62(5):623โ€“632.
Erol A, Karpyak VM. Sex and gender-related differences in alcohol use. Alcohol. 2015;49(4):369โ€“375.
Estruch R et al. Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine. 2018;378(25).
Fang Y et al. Mapping global prevalence of menopausal symptoms: systematic review and meta-analysis. BMC Public Health. 2024;24:1767. [482,067 women ยท 321 studies]
Freeman EW et al. Associations of hormones and menopausal status with depressed mood. Archives of General Psychiatry. 2006;63(4):375โ€“382.
Freeman EW et al. Sleep disturbance and hormone levels in midlife. Sleep Medicine Reviews. 2007.
Kravitz HM, Joffe H. Sleep during the perimenopause: a SWAN story. Obstetrics and Gynecology Clinics of North America. 2011;38(3):567โ€“586.
Laukkanen JA et al. Association between sauna bathing and fatal cardiovascular and all-cause mortality. JAMA Internal Medicine. 2015;175(4):542โ€“548.
Littarru GP, Tiano L. Clinical aspects of coenzyme Q10: an update. Nutrition. 2010;26(3):250โ€“254.
Lovejoy JC et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. International Journal of Obesity. 2008;32(6):949โ€“958.
Manson JE et al. Menopausal hormone therapy and health outcomes during and after the WHI. JAMA. 2013;310(13):1353โ€“1368.
Mauvais-Jarvis F et al. Menopause, estrogens, and glucose homeostasis in women. Journal of Diabetes Investigation. 2013;4(3):274โ€“279.
McEwen BS. Estrogen actions throughout the brain. Recent Progress in Hormone Research. 2002;57:357โ€“384.
MIDUS. Midlife in the United States Longitudinal Study. University of Wisconsin Institute on Aging. Ongoing since 1994. Available at: midus.wisc.edu.
Ohayon MM. Severe hot flashes associated with chronic insomnia. Archives of Internal Medicine. 2006;166(12):1262โ€“1268.
Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy. Menopause. 2014;21(10):1063โ€“1068.
Quinn PO, Madhoo M. ADHD in women and girls: uncovering this hidden diagnosis. The Primary Care Companion for CNS Disorders. 2014.
Rahn DD et al. Vaginal estrogen for genitourinary syndrome of menopause. Obstetrics & Gynecology. 2014;124(6):1147โ€“1156.
Rossouw JE et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women (WHI). JAMA. 2002;288(3):321โ€“333.
Ryff CD. Psychological well-being revisited: eudaimonia and health. Psychotherapy and Psychosomatics. 2014;83(1):10โ€“28.
Shanmugan S, Epperson CN. Estrogen and the prefrontal cortex: executive functions in the menopause transition. Human Brain Mapping. 2014;35(2):847โ€“865.
Sherwin BB. Estrogen and cognitive functioning in women. Behavioural Neuroscience. 2012;126(1):123โ€“127.
Smith-Ryan AE et al. Creatine supplementation in women's health: a lifespan perspective. Nutrients. 2021;13(3):877.
Sofi F et al. Benefits of adherence to the Mediterranean diet: systematic review and meta-analysis. American Journal of Clinical Nutrition. 2010;92(5):1189โ€“1196.
Staller J, Faraone SV. Attention-deficit hyperactivity disorder in girls. Expert Review of Neurotherapeutics. 2006;6(4):565โ€“572.
Studenski SA et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50โ€“58.
Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021;384:989โ€“1002.
Yoshino J et al. Nicotinamide mononucleotide, a key NAD+ intermediate. Cell Metabolism. 2018;27(5):1194.
Longitudinal Cohort Studies
MIDUS โ€” Midlife in the United States. University of Wisconsin. midus.wisc.edu โ€” tracking thousands of women across decades for health, wellbeing, and longevity outcomes.
SWAN โ€” Study of Women's Health Across the Nation. Multi-site longitudinal study tracking women through the menopausal transition. swanstudy.org.
WHI โ€” Women's Health Initiative. National Institutes of Health. whi.org โ€” long-term health study of postmenopausal women including the original 2002 HRT trial and subsequent analyses.

All content in Her Guide is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. The research cited here is provided to support informed conversations with your healthcare team. Always consult a licensed healthcare provider before making changes to your health routine.

midlifebridge